<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d567">
    <sentence id="DDI-DrugBank.d567.s0" text="CYP3A4 Interactions"/>
    <sentence id="DDI-DrugBank.d567.s1" text="Lovastatin is metabolized by CYP3A4 but has no CYP3A4 inhibitory activity;">
        <entity charOffset="0-9" id="DDI-DrugBank.d567.s1.e0" text="Lovastatin" type="drug"/>
    <negationtags>Lovastatin is metabolized by CYP3A4 but has &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; CYP3A4 inhibitory activity; &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d567.s2" text="therefore it is not expected to affect the plasma concentrations of other drugs metabolized by CYP3A4."><negationtags>therefore it is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; expected to affect the plasma concentrations of other drugs metabolized by CYP3A4. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d567.s3" text="Potent inhibitors of CYP3A4 (below) increase the risk of myopathy by reducing the elimination of lovastatin.">
        <entity charOffset="97-106" id="DDI-DrugBank.d567.s3.e0" text="lovastatin" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s4" text="Pharmacokinetics."/>
    <sentence id="DDI-DrugBank.d567.s5" text="Itraconazole Ketoconazole Erythromycin Clarithromycin Telithromycin HIV protease inhibitors Nefazodone Cyclosporine Large quantities of grapefruit juice ( 1 quart daily)">
        <entity charOffset="0-11" id="DDI-DrugBank.d567.s5.e0" text="Itraconazole" type="drug"/>
        <entity charOffset="13-24" id="DDI-DrugBank.d567.s5.e1" text="Ketoconazole" type="drug"/>
        <entity charOffset="26-37" id="DDI-DrugBank.d567.s5.e2" text="Erythromycin" type="drug"/>
        <entity charOffset="39-52" id="DDI-DrugBank.d567.s5.e3" text="Clarithromycin" type="drug"/>
        <entity charOffset="54-66" id="DDI-DrugBank.d567.s5.e4" text="Telithromycin" type="drug"/>
        <entity charOffset="68-90" id="DDI-DrugBank.d567.s5.e5" text="HIV protease inhibitors" type="group"/>
        <entity charOffset="92-101" id="DDI-DrugBank.d567.s5.e6" text="Nefazodone" type="drug"/>
        <entity charOffset="103-114" id="DDI-DrugBank.d567.s5.e7" text="Cyclosporine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e0" e2="DDI-DrugBank.d567.s5.e1" id="DDI-DrugBank.d567.s5.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e0" e2="DDI-DrugBank.d567.s5.e2" id="DDI-DrugBank.d567.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e0" e2="DDI-DrugBank.d567.s5.e3" id="DDI-DrugBank.d567.s5.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e0" e2="DDI-DrugBank.d567.s5.e4" id="DDI-DrugBank.d567.s5.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e0" e2="DDI-DrugBank.d567.s5.e5" id="DDI-DrugBank.d567.s5.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e0" e2="DDI-DrugBank.d567.s5.e6" id="DDI-DrugBank.d567.s5.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e0" e2="DDI-DrugBank.d567.s5.e7" id="DDI-DrugBank.d567.s5.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e1" e2="DDI-DrugBank.d567.s5.e2" id="DDI-DrugBank.d567.s5.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e1" e2="DDI-DrugBank.d567.s5.e3" id="DDI-DrugBank.d567.s5.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e1" e2="DDI-DrugBank.d567.s5.e4" id="DDI-DrugBank.d567.s5.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e1" e2="DDI-DrugBank.d567.s5.e5" id="DDI-DrugBank.d567.s5.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e1" e2="DDI-DrugBank.d567.s5.e6" id="DDI-DrugBank.d567.s5.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e1" e2="DDI-DrugBank.d567.s5.e7" id="DDI-DrugBank.d567.s5.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e2" e2="DDI-DrugBank.d567.s5.e3" id="DDI-DrugBank.d567.s5.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e2" e2="DDI-DrugBank.d567.s5.e4" id="DDI-DrugBank.d567.s5.p14"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e2" e2="DDI-DrugBank.d567.s5.e5" id="DDI-DrugBank.d567.s5.p15"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e2" e2="DDI-DrugBank.d567.s5.e6" id="DDI-DrugBank.d567.s5.p16"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e2" e2="DDI-DrugBank.d567.s5.e7" id="DDI-DrugBank.d567.s5.p17"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e3" e2="DDI-DrugBank.d567.s5.e4" id="DDI-DrugBank.d567.s5.p18"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e3" e2="DDI-DrugBank.d567.s5.e5" id="DDI-DrugBank.d567.s5.p19"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e3" e2="DDI-DrugBank.d567.s5.e6" id="DDI-DrugBank.d567.s5.p20"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e3" e2="DDI-DrugBank.d567.s5.e7" id="DDI-DrugBank.d567.s5.p21"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e4" e2="DDI-DrugBank.d567.s5.e5" id="DDI-DrugBank.d567.s5.p22"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e4" e2="DDI-DrugBank.d567.s5.e6" id="DDI-DrugBank.d567.s5.p23"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e4" e2="DDI-DrugBank.d567.s5.e7" id="DDI-DrugBank.d567.s5.p24"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e5" e2="DDI-DrugBank.d567.s5.e6" id="DDI-DrugBank.d567.s5.p25"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e5" e2="DDI-DrugBank.d567.s5.e7" id="DDI-DrugBank.d567.s5.p26"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s5.e6" e2="DDI-DrugBank.d567.s5.e7" id="DDI-DrugBank.d567.s5.p27"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s6" text="Interactions with lipid-lowering drugs that can cause myopathy when given alone."/>
    <sentence id="DDI-DrugBank.d567.s7" text="The risk of myopathy is also increased by the following lipid-lowering drugs that are not potent CYP3A4 inhibitors, but which can cause myopathy when given alone."><negationtags>The risk of myopathy is also increased by the following lipid-lowering drugs that are &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; potent CYP3A4 inhibitors, &lt;/scope&gt; but which can cause myopathy when given alone.</negationtags></sentence>
    <sentence id="DDI-DrugBank.d567.s8" text="See WARNINGS, Myopathy/Rhabdomyolysis."/>
    <sentence id="DDI-DrugBank.d567.s9" text="Gemfibrozil Other fibrates Niacin (nicotinic acid) (=1 g/day)">
        <entity charOffset="0-10" id="DDI-DrugBank.d567.s9.e0" text="Gemfibrozil" type="drug"/>
        <entity charOffset="18-25" id="DDI-DrugBank.d567.s9.e1" text="fibrates" type="group"/>
        <entity charOffset="27-32" id="DDI-DrugBank.d567.s9.e2" text="Niacin" type="drug"/>
        <entity charOffset="35-48" id="DDI-DrugBank.d567.s9.e3" text="nicotinic acid" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s9.e0" e2="DDI-DrugBank.d567.s9.e1" id="DDI-DrugBank.d567.s9.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s9.e0" e2="DDI-DrugBank.d567.s9.e2" id="DDI-DrugBank.d567.s9.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s9.e0" e2="DDI-DrugBank.d567.s9.e3" id="DDI-DrugBank.d567.s9.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s9.e1" e2="DDI-DrugBank.d567.s9.e2" id="DDI-DrugBank.d567.s9.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s9.e1" e2="DDI-DrugBank.d567.s9.e3" id="DDI-DrugBank.d567.s9.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s9.e2" e2="DDI-DrugBank.d567.s9.e3" id="DDI-DrugBank.d567.s9.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s10" text="Other drug interactions"/>
    <sentence id="DDI-DrugBank.d567.s11" text="Danazol: The risk of myopathy/rhabdomyolysis is increased by concomitant administration of danazol particularly with higher doses of lovastatin (see WARNINGS, Myopathy/Rhabdomyolysis).">
        <entity charOffset="0-6" id="DDI-DrugBank.d567.s11.e0" text="Danazol" type="drug"/>
        <entity charOffset="91-97" id="DDI-DrugBank.d567.s11.e1" text="danazol" type="drug"/>
        <entity charOffset="133-142" id="DDI-DrugBank.d567.s11.e2" text="lovastatin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s11.e0" e2="DDI-DrugBank.d567.s11.e1" id="DDI-DrugBank.d567.s11.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s11.e0" e2="DDI-DrugBank.d567.s11.e2" id="DDI-DrugBank.d567.s11.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d567.s11.e1" e2="DDI-DrugBank.d567.s11.e2" id="DDI-DrugBank.d567.s11.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s12" text="Amiodarone or Verapamil: The risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the HMG-CoA reductase inhibitor class (see WARNINGS, Myopathy/Rhabdomyolysis).">
        <entity charOffset="0-9" id="DDI-DrugBank.d567.s12.e0" text="Amiodarone" type="drug"/>
        <entity charOffset="14-22" id="DDI-DrugBank.d567.s12.e1" text="Verapamil" type="drug"/>
        <entity charOffset="86-95" id="DDI-DrugBank.d567.s12.e2" text="amiodarone" type="drug"/>
        <entity charOffset="100-108" id="DDI-DrugBank.d567.s12.e3" text="verapamil" type="drug"/>
        <entity charOffset="169-201" id="DDI-DrugBank.d567.s12.e4" text="HMG-CoA reductase inhibitor class" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s12.e0" e2="DDI-DrugBank.d567.s12.e1" id="DDI-DrugBank.d567.s12.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s12.e0" e2="DDI-DrugBank.d567.s12.e2" id="DDI-DrugBank.d567.s12.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s12.e0" e2="DDI-DrugBank.d567.s12.e3" id="DDI-DrugBank.d567.s12.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s12.e0" e2="DDI-DrugBank.d567.s12.e4" id="DDI-DrugBank.d567.s12.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s12.e1" e2="DDI-DrugBank.d567.s12.e2" id="DDI-DrugBank.d567.s12.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s12.e1" e2="DDI-DrugBank.d567.s12.e3" id="DDI-DrugBank.d567.s12.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s12.e1" e2="DDI-DrugBank.d567.s12.e4" id="DDI-DrugBank.d567.s12.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s12.e2" e2="DDI-DrugBank.d567.s12.e3" id="DDI-DrugBank.d567.s12.p7"/>
        <pair ddi="true" e1="DDI-DrugBank.d567.s12.e2" e2="DDI-DrugBank.d567.s12.e4" id="DDI-DrugBank.d567.s12.p8" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d567.s12.e3" e2="DDI-DrugBank.d567.s12.e4" id="DDI-DrugBank.d567.s12.p9" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s13" text="Coumarin Anticoagulants: In a small clinical trial in which lovastatin was administered to warfarin treated patients, no effect on prothrombin time was detected.">
        <entity charOffset="0-21" id="DDI-DrugBank.d567.s13.e0" text="Coumarin Anticoagulant" type="group"/>
        <entity charOffset="60-69" id="DDI-DrugBank.d567.s13.e1" text="lovastatin" type="drug"/>
        <entity charOffset="91-98" id="DDI-DrugBank.d567.s13.e2" text="warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s13.e0" e2="DDI-DrugBank.d567.s13.e1" id="DDI-DrugBank.d567.s13.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s13.e0" e2="DDI-DrugBank.d567.s13.e2" id="DDI-DrugBank.d567.s13.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s13.e1" e2="DDI-DrugBank.d567.s13.e2" id="DDI-DrugBank.d567.s13.p2"/>
    <negationtags>Coumarin Anticoagulants: In a small clinical trial in which lovastatin was administered to warfarin treated patients, &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; effect on prothrombin time was detected. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d567.s14" text="However, another HMG-CoA reductase inhibitor has been found to produce a less than two-second increase in prothrombin time in healthy volunteers receiving low doses of warfarin.">
        <entity charOffset="17-43" id="DDI-DrugBank.d567.s14.e0" text="HMG-CoA reductase inhibitor" type="group"/>
        <entity charOffset="168-175" id="DDI-DrugBank.d567.s14.e1" text="warfarin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d567.s14.e0" e2="DDI-DrugBank.d567.s14.e1" id="DDI-DrugBank.d567.s14.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s15" text="Also, bleeding and/or increased prothrombin time have been reported in a few patients taking coumarin anticoagulants concomitantly with lovastatin.">
        <entity charOffset="93-114" id="DDI-DrugBank.d567.s15.e0" text="coumarin anticoagulant" type="group"/>
        <entity charOffset="136-145" id="DDI-DrugBank.d567.s15.e1" text="lovastatin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d567.s15.e0" e2="DDI-DrugBank.d567.s15.e1" id="DDI-DrugBank.d567.s15.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s16" text="It is recommended that in patients taking anticoagulants, prothrombin time be determined before starting lovastatin and frequently enough during early therapy to insure that no significant alteration of prothrombin time occurs.">
        <entity charOffset="42-55" id="DDI-DrugBank.d567.s16.e0" text="anticoagulants" type="group"/>
        <entity charOffset="105-114" id="DDI-DrugBank.d567.s16.e1" text="lovastatin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d567.s16.e0" e2="DDI-DrugBank.d567.s16.e1" id="DDI-DrugBank.d567.s16.p0" type="advise"/>
    <negationtags>It is recommended that in patients taking anticoagulants, prothrombin time be determined before starting lovastatin and frequently enough during early therapy to insure that &lt;scope&gt; &lt;cue&gt; no significant &lt;/cue&gt; alteration of prothrombin time occurs. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d567.s17" text="Once a stable prothrombin time has been documented, prothrombin times can be monitored at the intervals usually recommended for patients on coumarin anticoagulants.">
        <entity charOffset="140-162" id="DDI-DrugBank.d567.s17.e0" text="coumarin anticoagulants" type="group"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s18" text="If the dose of lovastatin is changed, the same procedure should be repeated.">
        <entity charOffset="15-24" id="DDI-DrugBank.d567.s18.e0" text="lovastatin" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d567.s19" text="Lovastatin therapy has not been associated with bleeding or with changes in prothrombin time in patients not taking anticoagulants.">
        <entity charOffset="0-9" id="DDI-DrugBank.d567.s19.e0" text="Lovastatin" type="drug"/>
        <entity charOffset="116-129" id="DDI-DrugBank.d567.s19.e1" text="anticoagulants" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s19.e0" e2="DDI-DrugBank.d567.s19.e1" id="DDI-DrugBank.d567.s19.p0"/>
    <negationtags>Lovastatin therapy has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been associated with bleeding or with changes in prothrombin time in patients not taking anticoagulants. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d567.s20" text="Propranolol: In normal volunteers, there was no clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of lovastatin and propranolol.">
        <entity charOffset="0-10" id="DDI-DrugBank.d567.s20.e0" text="Propranolol" type="drug"/>
        <entity charOffset="169-178" id="DDI-DrugBank.d567.s20.e1" text="lovastatin" type="drug"/>
        <entity charOffset="184-194" id="DDI-DrugBank.d567.s20.e2" text="propranolol" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s20.e0" e2="DDI-DrugBank.d567.s20.e1" id="DDI-DrugBank.d567.s20.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s20.e0" e2="DDI-DrugBank.d567.s20.e2" id="DDI-DrugBank.d567.s20.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s20.e1" e2="DDI-DrugBank.d567.s20.e2" id="DDI-DrugBank.d567.s20.p2"/>
    <negationtags>Propranolol: In normal volunteers, there was &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of lovastatin and propranolol. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d567.s21" text="Digoxin: In patients with hypercholesterolemia, concomitant administration of lovastatin and digoxin resulted in no effect on digoxin plasma concentrations.">
        <entity charOffset="0-6" id="DDI-DrugBank.d567.s21.e0" text="Digoxin" type="drug"/>
        <entity charOffset="78-87" id="DDI-DrugBank.d567.s21.e1" text="lovastatin" type="drug"/>
        <entity charOffset="93-99" id="DDI-DrugBank.d567.s21.e2" text="digoxin" type="drug"/>
        <entity charOffset="126-132" id="DDI-DrugBank.d567.s21.e3" text="digoxin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s21.e0" e2="DDI-DrugBank.d567.s21.e1" id="DDI-DrugBank.d567.s21.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s21.e0" e2="DDI-DrugBank.d567.s21.e2" id="DDI-DrugBank.d567.s21.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s21.e0" e2="DDI-DrugBank.d567.s21.e3" id="DDI-DrugBank.d567.s21.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s21.e1" e2="DDI-DrugBank.d567.s21.e2" id="DDI-DrugBank.d567.s21.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s21.e1" e2="DDI-DrugBank.d567.s21.e3" id="DDI-DrugBank.d567.s21.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s21.e2" e2="DDI-DrugBank.d567.s21.e3" id="DDI-DrugBank.d567.s21.p5"/>
    <negationtags>Digoxin: In patients with hypercholesterolemia, concomitant administration of lovastatin and digoxin resulted in &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; effect on digoxin plasma concentrations. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d567.s22" text="Oral Hypoglycemic Agents: In pharmacokinetic studies of MEVACOR in hypercholesterolemic noninsulin dependent diabetic patients, there was no drug interaction with glipizide or with chlorpropamide">
        <entity charOffset="5-23" id="DDI-DrugBank.d567.s22.e0" text="Hypoglycemic Agents" type="group"/>
        <entity charOffset="56-62" id="DDI-DrugBank.d567.s22.e1" text="MEVACOR" type="brand"/>
        <entity charOffset="163-171" id="DDI-DrugBank.d567.s22.e2" text="glipizide" type="drug"/>
        <entity charOffset="181-194" id="DDI-DrugBank.d567.s22.e3" text="chlorpropamide" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s22.e0" e2="DDI-DrugBank.d567.s22.e1" id="DDI-DrugBank.d567.s22.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s22.e0" e2="DDI-DrugBank.d567.s22.e2" id="DDI-DrugBank.d567.s22.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s22.e0" e2="DDI-DrugBank.d567.s22.e3" id="DDI-DrugBank.d567.s22.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s22.e1" e2="DDI-DrugBank.d567.s22.e2" id="DDI-DrugBank.d567.s22.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s22.e1" e2="DDI-DrugBank.d567.s22.e3" id="DDI-DrugBank.d567.s22.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d567.s22.e2" e2="DDI-DrugBank.d567.s22.e3" id="DDI-DrugBank.d567.s22.p5"/>
    <negationtags>Oral Hypoglycemic Agents: In pharmacokinetic studies of MEVACOR in hypercholesterolemic noninsulin dependent diabetic patients, there was &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; drug interaction with glipizide or with chlorpropamide &lt;/scope&gt;</negationtags></sentence>
</document>